Immunhistochemistry (IHC) on formalin fixed tissues is a major application for antibodies. However, most of the commercially available antibodies do not perform appropriately in IHC. The few antibodies that do work well are usually not known to the scientific community because the existing antibodies are not adequately validated. Cross-reactivities (strong binding to another than the target protein) and non-specific binding are the major causes for false IHC results. Many established and IVD/IVDR classified antibodies suffer from significant cross-reactivities resulting in false positivity’s. Appropriate validation of antibodies inevitably requires the use of large numbers of different tissues. Tissue microarrays (TMAs) enable the simultaneous analysis of more than 600 tissues per section. Studies including thousands of tissues can be executed within days if appropriate TMAs are available. Such clinical studies can evaluate and demonstrate the clinical utility of antibodies and combination of antibodies very rapidly.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Bergstedter Chaussee 62a, Hamburg,hh 22395,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ardoci.com
- HQ
- Hamburg, HH
Ardoci Gmbh Questions
Ardoci Gmbh's website is https://ardoci.com
Ardoci Gmbh's LinkedIn profile is https://de.linkedin.com/company/ardoci-gmbh
Ardoci Gmbh has
1 employees.
View email and phone details for 1
employees at Ardoci Gmbh.
Ardoci Gmbh's industry is
Biotechnology Research
Ardoci Gmbh's top competitors are
Melyad,
Claremont Biosolutions, Llc,
Myoptions.co,
Ms Validated Antibodies Gmbh,
Lab Link,
Asteryos,
Dcn Dx,
Gateway Factory,
Fluxergy,
Biodot, Inc.
Ardoci Gmbh's categories are Biotechnology Research
Ardoci Gmbh's founding year is 2023
